These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21035945)

  • 1. A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.
    Wang F; Zhai S; Liu X; Li L; Wu S; Dou QP; Yan B
    Cancer Lett; 2011 Jan; 300(1):87-95. PubMed ID: 21035945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues.
    Yu Z; Wang F; Milacic V; Li X; Cui QC; Zhang B; Yan B; Dou QP
    Int J Mol Med; 2007 Dec; 20(6):919-25. PubMed ID: 17982703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
    Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
    Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis.
    Chen D; Peng F; Cui QC; Daniel KG; Orlu S; Liu J; Dou QP
    Front Biosci; 2005 Sep; 10():2932-9. PubMed ID: 15970547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells.
    Oh DH; Bang JS; Choi HM; Yang HI; Yoo MC; Kim KS
    Eur J Pharmacol; 2010 Dec; 649(1-3):135-9. PubMed ID: 20868670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
    Chen D; Cui QC; Yang H; Dou QP
    Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
    Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
    Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.
    Milacic V; Chen D; Giovagnini L; Diez A; Fregona D; Dou QP
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):24-33. PubMed ID: 18501397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of disulfiram and H
    Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
    Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
    Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
    J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
    Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
    Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
    Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper.
    Nobel CI; Kimland M; Lind B; Orrenius S; Slater AF
    J Biol Chem; 1995 Nov; 270(44):26202-8. PubMed ID: 7592825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular study on copper-mediated tumor proteasome inhibition and cell death.
    Xiao Y; Chen DI; Zhang X; Cui Q; Fan Y; Bi C; Dou QP
    Int J Oncol; 2010 Jul; 37(1):81-87. PubMed ID: 20514399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.
    Brahemi G; Kona FR; Fiasella A; Buac D; Soukupová J; Brancale A; Burger AM; Westwell AD
    J Med Chem; 2010 Apr; 53(7):2757-65. PubMed ID: 20222671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.